| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.097 | 0.03 |